Menu
Fechar
hrs4r
Quiero donar
Firma
ARANTXA ERASO-URIÉN
Posición
Cap de Grup - R4
Jefe de Grupo - R4
Projectes
Publicacions

Projectes

Genética Cardiovascular

Impacto de un programa estructurado de ejercicio físico y control de factores de riesgo cardiovasculares en prevención primaria de cardiotoxicidad en pacientes con cáncer de mama sometidos a tratamientos cardiotóxicos: Estudio PREV

Codi oficial: Estudio PREV Data inicio:01/11/2021 Data fi: 31/12/2025 Investigador/a principal: ARANTXA ERASO URIÉN, SERGI MORAL TORRES Organisme finançador: FUNDACION MERCK SALUD Ajuda: 0 €
Oncología Radioterápica y Física Médica de Girona

Linfadenectomía axilar versus radioterapia axilar en pacientes con ganglio centinela positivo tras terapia neodyuvante. Estudio multicéntrico randomizado fase III.

Codi oficial: ADARNAT I Data inicio:09/12/2022 Data fi: 09/12/2027 Investigador/a principal: LUIS MIGUEL ALONSO RUANO, ARANTXA ERASO URIÉN Organisme finançador: ASSOCIACIÓ ESPANYOLA CONTRA EL CÀNCER Ajuda: 0 €
Oncología Radioterápica y Física Médica de Girona

Ajuts per donar suport a les activitats dels grups de recerca de Catalunya (SGR-Cat 2021) - Oncologia radioteràpica i Física Mèdica de Girona (ONCORFIM Girona)

Codi oficial: 2021 SGR 01463 - ONCORFIM Girona Data inicio:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: ARANTXA ERASO URIÉN Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 24,000 €

Publicacions

Marruecos-Querol J, Rubió-Casadevall J, Lozano A, Buxó M, Puigdemont M, Linares I, Planas I, Vayreda J, Cirauqui B, Taberna M, Quiroga V, Tobed M, Borés A, Recalde S, Saigi M, Felip E, Eraso A, Mesía R

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25, 2384-2392 dx.doi.org/10.1007/s12094-023-03121-9
Auñón C, Sanvisens A, Turon E, Vidal-Vila A, Puigdemont M, Osca-Gelis G, Eraso A, Marcos-Gragera R

Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).

CANCER MEDICINE, 2023, 12, 12343-12353 dx.doi.org/10.1002/cam4.5935
Pardo García R, Piñero Madrona A, Algara López M, Bernet Vegué L, Eraso Urien A

Just medical oncology guidelines….

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023 dx.doi.org/10.1007/s12094-023-03272-9
Coma N, Resta H, Moral S, Eraso MA, Ventura M, Brugada R

Uncommon short- and long-term cardiological side effects of thoracic radiation: a report of two cases.

Future Cardiology, 2023 dx.doi.org/10.2217/fca-2023-0027
Sanz J, Eraso A, Ibáñez R, Williams R, Algara M

Tumor Bed Boost Radiotherapy in the Conservative Treatment of Breast Cancer: A Review of Intra-Operative Techniques and Outcomes.

Cancers, 2023, 15 dx.doi.org/10.3390/cancers15164025
Laplana, M, Garcia-Marqueta, M, Sanchez-Fernandez, JJ, Martinez-Perez, E, Perez-Montero, H, Martinez-Montesinos, I, Eraso, A, Saldana, P, Martin, R, Martin, MI, Pla, MJ, Garcia-Tejedor, A, Guedea, F

Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy X-rays (INTRABEAM(R)) for accelerated partial breast irradiation (APBI)

CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24, 1732-1743 dx.doi.org/10.1007/s12094-022-02823-w
Eraso A, Sanz J, Mollà M, Reyes V, Pedro A, Arenas M, Martinez E, Ballester R, Cambra MJ, García V, Prades JL, Borras JM, Algara M

Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24, 1580-1587 dx.doi.org/10.1007/s12094-022-02798-8
Locquet, M, Spoor, D, Crijns, A, van der Harst, P, Eraso, A, Guedea, F, Fiuza, M, Santos, SCR, Combs, S, Borm, K, Mousseaux, E, Gencer, U, Frija, G, Cardis, E, Langendijk, H, Jacob, S

Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY-HEART study)

Frontiers in oncology, 2022, 12, 883679-883679 dx.doi.org/10.3389/fonc.2022.883679
Zamora V, Garin O, Pardo Y, Pont À, Gutiérrez C, Cabrera P, Gómez-Veiga F, Pijoan JI, Litwin MS, Ferrer M, Multicentric Spanish Group of Clinically Localized Prostate Cancer

Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys

VALUE IN HEALTH, 2021, 24, 1676-1685 dx.doi.org/10.1016/j.jval.2021.03.021
Borras JM, Font R, Solà J, Macia M, Tuset V, Arenas M, Eraso A, Verges R, Farré N, Pedro A, Mollà M, Algara M, Solé JM, Mira M, Espinàs JA

Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain

RADIOTHERAPY AND ONCOLOGY, 2020, 151, 200-205 dx.doi.org/10.1016/j.radonc.2020.08.002

Formulari de contacte

Conoce el IDIBGI!

 menu